FindTrial
Sign In

Transjugular Intrahepatic Portosystemic Shunt for Cavernous Transformation of Portal Vein: Classification and Clinical Outcomes

Transjugular Intrahepatic Portosystemic Shunt for Cavernous Transformation of Portal Vein: Classification and Clinical Outcomes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050593
Enrollment
Unknown
Registered
2021-09-01
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cavernous Transformation of Portal Vein

Interventions

sufficient inflow group:None
insufficient inflow group:None

Sponsors

The Third Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with portal hypertension and cavernous transformation of portal vein were included.

Exclusion criteria

Exclusion criteria: Patients with malignancy other than myeloproliferative neoplasm were excluded.

Design outcomes

Primary

MeasureTime frame
shunt patency;—

Secondary

MeasureTime frame
recurrence of portal hypertension;—

Countries

China

Contacts

Public ContactJiang Zaibo

The Third Affiliated Hospital of Sun Yat-Sen University

jiangzbo@mail.sysu.edu.cn+86 20 85252066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026